Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.65M | $1.62M | +63.03% |
Operating Income | $-509.81M | $-401.98M | -26.82% |
Net Income | $-450.99M | $-328.94M | -37.10% |
EPS (Basic) | $-5.12 | $-3.92 | -30.61% |
EPS (Diluted) | $-5.12 | $-3.92 | -30.61% |
R&D Expense | $201.28M | $238.5M | -15.61% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.25B | $2.26B | -0.48% |
Current Assets | $1.93B | $1.94B | -0.76% |
Total Liabilities | $329.33M | $316.47M | +4.06% |
Current Liabilities | $118.96M | $89.81M | +32.45% |
Stockholders' Equity | $1.92B | $1.94B | -1.22% |
Cash & Equivalents | $286.5M | $225.67M | +26.95% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-252.46M | $-92.74M | -172.22% |
Investing Cash Flow | $-69M | $-386.31M | +82.14% |
Financing Cash Flow | $309.61M | $315.11M | -1.74% |
D&A | $13.82M | $14.42M | -4.15% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -19267.1% | -24767.6% | +5500.51% |
Net Margin | -17044.1% | — | — |
ROE | -23.5% | — | — |
ROA | -20.1% | — | — |
Current Ratio | $16.217 | — | — |
Debt to Equity | $0.172 | — | — |
Other companies in Biotechnology